Overview Civamide in OA of the Knee(s) Status: Completed Trial end date: 2005-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s). Phase: Phase 3 Details Lead Sponsor: Winston LaboratoriesTreatments: Capsaicin